1. Home
  2. BNKK vs TCRT Comparison

BNKK vs TCRT Comparison

Compare BNKK & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BNKK

Bonk Inc.

N/A

Current Price

$1.08

Market Cap

9.4M

ML Signal

N/A

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

N/A

Current Price

$1.90

Market Cap

7.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BNKK
TCRT
Founded
2018
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4M
7.8M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
BNKK
TCRT
Price
$1.08
$1.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
96.6K
★ 12.7M
Earning Date
11-18-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 24.66
EPS
N/A
★ N/A
Revenue
$2,117,309.00
★ $15,900,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 201.63
N/A
52 Week Low
$0.90
$0.72
52 Week High
$155.05
$4.50

Technical Indicators

Market Signals
Indicator
BNKK
TCRT
Relative Strength Index (RSI) 38.80 49.22
Support Level $0.91 $1.78
Resistance Level $1.47 $2.49
Average True Range (ATR) 0.11 0.76
MACD -0.01 -0.07
Stochastic Oscillator 40.91 13.49

Price Performance

Historical Comparison
BNKK
TCRT

About BNKK Bonk Inc.

Bonk Inc provides over-the-counter products and consumer products in the United States. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It sells its products through direct customers, distributors, retailers, and e-commerce websites. The company generates revenue through various channels, its primary sales include nostingz suncare products which are sold through e-commerce platforms, licensing revenues from Photocil and sales of the Safety Shot Beverage. The company has two reportable segments: the dietary and energy beverage business and digital assets, consisting of investing for growth in the appreciation of the asset. It derives the majority of the revenue from the dietary and energy beverage segment.

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

Share on Social Networks: